PURPOSE: The aim of this study was to compare the precision of two different methods in detecting clinical depression in tumor patients: the use of a screening questionnaire versus the assessment by health care providers (nurses and doctors). METHODS: During their first days of inpatient cancer treatment, tumor patients were interviewed using the Structured Clinical Interview for DSM (SCID). Their physicians and nurses were asked to assess the mental health of the patients and their need for professional psychosocial support. Additionally, every patient completed the Hospital Anxiety and Depression Scale (HADS). RESULTS: Out of 329 patients, 28 were diagnosed with either a major or a minor depression according to the SCID. Physicians assessed 15 of the depressed patients as being depressed (sensitivity, 0.54; specificity, 0.38). Nurses identified 19 (sensitivity, 0.68; specificity, 0.45) and the HADS 27 (sensitivity, 0.96; specificity, 0.50) of the depressed patients. CONCLUSION: The HADS performed well in detecting depressed cancer patients in acute oncological care, whereas physicians and nurses often were unable to recognize depressed patients.
PURPOSE: The aim of this study was to compare the precision of two different methods in detecting clinical depression in tumorpatients: the use of a screening questionnaire versus the assessment by health care providers (nurses and doctors). METHODS: During their first days of inpatient cancer treatment, tumorpatients were interviewed using the Structured Clinical Interview for DSM (SCID). Their physicians and nurses were asked to assess the mental health of the patients and their need for professional psychosocial support. Additionally, every patient completed the Hospital Anxiety and Depression Scale (HADS). RESULTS: Out of 329 patients, 28 were diagnosed with either a major or a minor depression according to the SCID. Physicians assessed 15 of the depressedpatients as being depressed (sensitivity, 0.54; specificity, 0.38). Nurses identified 19 (sensitivity, 0.68; specificity, 0.45) and the HADS 27 (sensitivity, 0.96; specificity, 0.50) of the depressedpatients. CONCLUSION: The HADS performed well in detecting depressed cancerpatients in acute oncological care, whereas physicians and nurses often were unable to recognize depressedpatients.
Authors: Gary Rodin; Nancy Lloyd; Mark Katz; Esther Green; Jean A Mackay; Rebecca K S Wong Journal: Support Care Cancer Date: 2006-10-21 Impact factor: 3.603
Authors: Catherine C Classen; Helena C Kraemer; Christine Blasey; Janine Giese-Davis; Cheryl Koopman; Oxana Gronskaya Palesh; Ami Atkinson; Sue Dimiceli; Gail Stonisch-Riggs; Joan Westendorp; Gary R Morrow; David Spiegel Journal: Psychooncology Date: 2008-05 Impact factor: 3.894
Authors: Colleen L Barry; Elizabeth A Stuart; Julie M Donohue; Shelly F Greenfield; Elena Kouri; Kenneth Duckworth; Zirui Song; Robert E Mechanic; Michael E Chernew; Haiden A Huskamp Journal: Health Aff (Millwood) Date: 2015-12 Impact factor: 6.301
Authors: Florien W Boele; Irma M Verdonck-de Leeuw; Pim Cuijpers; Jaap C Reijneveld; Jan J Heimans; Martin Klein Journal: BMC Neurol Date: 2014-04-10 Impact factor: 2.474